NEW ROGAINE FOAM FEATURES CONNETICS' PROPRIETARY VERSAFOAM DELIVERY TECHNOLOGY

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announces the use of its proprietary VersaFoam technology in Pfizer Consumer Healthcare's new Men's Rogaine Foam, now available wherever Rogaine is sold. In January 2006, Pfizer received FDA approval for Men's Rogaine Foam (minoxidil, 5%) developed under a license from Connetics' VersaFoam technology.
Business Wire